Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-19T00:16:05.757Z.
Calculation as of: 2026-09-19T00:16:05.757Z.
Quote observation: 2026-09-18T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 28c109353c75d8b12db6c684d1955bfcc91a189e8f042ac4261563e744a70cce
PEG RATIO
N/A
Viatris Inc.
Market Cap
$19.74B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Viatris Inc. (VTRS) | $19.74B | N/A |
| STERIS plc (STE)vs › | $19.98B | N/A |
| United Therapeutics Corporation (UTHR)vs › | $21.00B | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.45B | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $17.09B | N/A |
| Revvity, Inc. (RVTY)vs › | $16.00B | N/A |
| Solventum Corporation (SOLV)vs › | $15.38B | N/A |
| BioNTech SE (BNTX)vs › | $24.13B | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.67B | N/A |
| Incyte Corporation (INCY)vs › | $25.40B | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
